Vascular Graft Market

Vascular Graft Market (Product - Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, and Bypass Graft; End User - Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Cardiac Catheterization Laboratories; Source - Synthetic, Biosynthetic and Biological; Application - Coronary Artery Disease, Aneurysm, Vascular Occlusion, and Renal Failure) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • Rep Id : TMRGL11096
  • Published On : May 2017
  • No. of Pages : 243
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vascular Grafts Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. Global Vascular Grafts Market Analysis and Forecasts,2014–2024
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s Five Force Analysis
     4.7. Market Outlook
     4.8.Global Prevalence of Chronic Kidney Diseases
     4.9.Prevalence of End Stage Renal Disorders 
     4.10.Patient Data for Dialysis (2016)
            4.10.1. Hemodialysis 
            4.10.2. Peritoneal Dialysis 
     4.11. Global Prevalence of Cardiovascular Diseases
     4.12. Overview of Cryopreservation Technique

5. Global Vascular Grafts Market Analysis and Forecasts, By Product Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product Type, 2014–2024
            5.4.1. Endovascular Stent Graft 
            5.4.2. Peripheral Vascular Graft 
            5.4.3. Hemodialysis Access Graft 
            5.4.4. Bypass Graft 
            5.4.5. Others
     5.5. Market Attractiveness By Product Type 

6. Global Vascular Grafts Market Analysis and Forecasts, By Source 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Source, 2014–2024
            6.4.1. Synthetic 
                     6.4.1.1. Polytetrafluethylene (PTFE)
                     6.4.1.2. Polyurethane (PU)
                     6.4.1.3. Dacron
                     6.4.1.4. Others
            6.4.2. Biological 
                     6.4.2.1. Bovine Vein
                     6.4.2.2. Saphenous Vein
                     6.4.2.3. Others
            6.4.3. Biosynthetic 
                     6.4.3.1. Ovine Collagen with Polyesters 
                     6.4.3.2. Others
     6.5. Market Attractiveness By Source 

7. Global Vascular Grafts Market Analysis and Forecasts, By Applications 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By Applications, 2014–2024
            7.4.1. Coronary Artery Disease
            7.4.2. Aneurysm
            7.4.3. Vascular Occlusion
            7.4.4. Renal Failure 
            7.4.5. Others
     7.5. Market Attractiveness By Applications

8. Global Vascular Grafts Market Analysis and Forecasts, By End Users 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value Forecast By End Users , 2014–2024
            8.4.1. Hospitals
            8.4.2. Ambulatory Surgery Centers
            8.4.3. Cardiac Catheterization Laboratories 
            8.4.4. Specialty Clinics 
            8.4.5. Others
     8.5. Market Attractiveness By End Users 

9. Global Vascular Grafts Market Analysis and Forecasts, By Region
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Value Forecast By Region
            9.3.1. North America 
            9.3.2. Europe 
            9.3.3. Asia Pacific 
            9.3.4. Latin America 
            9.3.5. Middle East & Africa 
     9.4. Market Attractiveness By Country/Region

10. North America Vascular Grafts Market Analysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2.Market Value Forecast By Product Type, 2014–2024
            10.2.1. Endovascular Stent Graft 
            10.2.2. Peripheral Vascular Graft 
            10.2.3. Hemodialysis Access Graft 
            10.2.4. Bypass Graft 
            10.2.5. Others
     10.3.Market Value Forecast By Source, 2014–2024
            10.3.1. Synthetic 
                     10.3.1.1. Polytetrafluethylene (PTFE)
                     10.3.1.2. Polyurethane (PU)
                     10.3.1.3. Dacron
                     10.3.1.4. Others
            10.3.2. Biological 
                     10.3.2.1. Bovine Vein
                     10.3.2.2. Saphenous Vein
                     10.3.2.3. Others
            10.3.3. Biosynthetic 
                     10.3.3.1. Ovine Collagen with Polyesters 
                     10.3.3.2. Others
     10.4.Market Value Forecast By Applications, 2014–2024
            10.4.1. Coronary Artery Disease
            10.4.2. Aneurysm
            10.4.3. Vascular Occlusion
            10.4.4. Renal Failure 
            10.4.5. Others
     10.5.Market Value Forecast By End Users, 2014–2024
            10.5.1. Hospitals
            10.5.2. Ambulatory Surgery Centers
            10.5.3. Cardiac Catheterization Laboratories 
            10.5.4. Specialty Clinics 
            10.5.5. Others
     10.6.Market Value Forecast By Country, 2014–2024
            10.6.1. U.S.
            10.6.2. Canada
     10.7.Market Attractiveness Analysis 
            10.7.1. By Product Type 
            10.7.2. By Source 
            10.7.3. By Applications
            10.7.4. By End Users 
            10.7.5. By Country

11. Europe Vascular Grafts Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
            11.1.3. Key Trends
     11.2.Market Value Forecast By Product Type, 2014–2024
            11.2.1. Endovascular Stent Graft 
            11.2.2. Peripheral Vascular Graft 
            11.2.3. Hemodialysis Access Graft 
            11.2.4. Bypass Graft 
            11.2.5. Others
     11.3.Market Value Forecast By Source, 2014–2024
            11.3.1. Synthetic 
                     11.3.1.1. Polytetrafluethylene (PTFE)
                     11.3.1.2. Polyurethane (PU)
                     11.3.1.3. Dacron
                     11.3.1.4. Others
            11.3.2. Biological 
                     11.3.2.1. Bovine Vein
                     11.3.2.2. Saphenous Vein
                     11.3.2.3. Others
            11.3.3. Biosynthetic 
                     11.3.3.1. Ovine Collagen with Polyesters 
                     11.3.3.2. Others
     11.4.Market Value Forecast By Applications, 2014–2024
            11.4.1. Coronary Artery Disease
            11.4.2. Aneurysm
            11.4.3. Vascular Occlusion
            11.4.4. Renal Failure 
            11.4.5. Others
     11.5.Market Value Forecast By End Users, 2014–2024
            11.5.1. Hospitals
            11.5.2. Ambulatory Surgery Centers
            11.5.3. Cardiac Catheterization Laboratories 
            11.5.4. Specialty Clinics 
            11.5.5. Others
     11.6.Market Value Forecast By Country, 2014–2024
            11.6.1. Germany 
            11.6.2. U.K.
            11.6.3. France
            11.6.4. Italy 
            11.6.5. Spain
            11.6.6. Russia
            11.6.7. Rest of Europe
     11.7.Market Attractiveness Analysis 
            11.7.1. By Product Type 
            11.7.2. By Source 
            11.7.3. By Applications 
            11.7.4. By End Users 
            11.7.5. By Country

12. Asia Pacific Vascular Grafts Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
            12.1.3. Key Trends
     12.2.Market Value Forecast By Product Type, 2014–2024
            12.2.1. Endovascular Stent Graft 
            12.2.2. Peripheral Vascular Graft 
            12.2.3. Hemodialysis Access Graft 
            12.2.4. Bypass Graft 
            12.2.5. Others
     12.3.Market Value Forecast By Source, 2014–2024
            12.3.1. Synthetic 
                     12.3.1.1. Polytetrafluethylene (PTFE)
                     12.3.1.2. Polyurethane (PU)
                     12.3.1.3. Dacron
                     12.3.1.4. Others
            12.3.2. Biological 
                     12.3.2.1. Bovine Vein
                     12.3.2.2. Saphenous Vein
                     12.3.2.3. Others
            12.3.3. Biosynthetic 
                     12.3.3.1. Ovine Collagen with Polyesters 
                     12.3.3.2. Others
     12.4.Market Value Forecast By Applications, 2014–2024
            12.4.1. Coronary Artery Disease
            12.4.2. Aneurysm
            12.4.3. Vascular Occlusion
            12.4.4. Renal Failure 
            12.4.5. Others
     12.5.Market Value Forecast By End Users, 2014–2024
            12.5.1. Hospitals
            12.5.2. Ambulatory Surgery Centers
            12.5.3. Cardiac Catheterization Laboratories 
            12.5.4. Specialty Clinics 
            12.5.5. Others
     12.6.Market Value Forecast By Country, 2014–2024
            12.6.1. China 
            12.6.2. India
            12.6.3. Japan 
            12.6.4. Australia & New Zealand
            12.6.5. Rest of Asia Pacific
     12.7.Market Attractiveness Analysis 
            12.7.1. By Product Type 
            12.7.2. By Source 
            12.7.3. By Applications
            12.7.4. By End Users 
            12.7.5. By Country

13. Latin America Vascular Grafts Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
            13.1.3. Key Trends
     13.2.Market Value Forecast By Product Type, 2014–2024
            13.2.1. Endovascular Stent Graft 
            13.2.2. Peripheral Vascular Graft 
            13.2.3. Hemodialysis Access Graft 
            13.2.4. Bypass Graft 
            13.2.5. Others
     13.3.Market Value Forecast By Source, 2014–2024
            13.3.1. Synthetic 
                     13.3.1.1. Polytetrafluethylene (PTFE)
                     13.3.1.2. Polyurethane (PU)
                     13.3.1.3. Dacron
                     13.3.1.4. Others
            13.3.2. Biological 
                     13.3.2.1. Bovine Vein
                     13.3.2.2. Saphenous Vein
                     13.3.2.3. Others
            13.3.3. Biosynthetic 
                     13.3.3.1. Ovine Collagen with Polyesters 
                     13.3.3.2. Others
     13.4.Market Value Forecast By Applications, 2014–2024
            13.4.1. Coronary Artery Disease
            13.4.2. Aneurysm
            13.4.3. Vascular Occlusion
            13.4.4. Renal Failure 
            13.4.5. Others
     13.5.Market Value Forecast By End Users, 2014–2024
            13.5.1. Hospitals
            13.5.2. Ambulatory Surgery Centers
            13.5.3. Cardiac Catheterization Laboratories 
            13.5.4. Specialty Clinics 
            13.5.5. Others
     13.6.Market Value Forecast By Country, 2014–2024
            13.6.1. Brazil
            13.6.2. Mexico 
            13.6.3. Rest of Latin America
     13.7.Market Attractiveness Analysis 
            13.7.1. By Product Type 
            13.7.2. By Source 
            13.7.3. By Applications
            13.7.4. By End Users 
            13.7.5. By Country

14. Middle East & Africa Vascular Grafts Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
            14.1.2. Policies and Regulations
            14.1.3. Key Trends
     14.2.Market Value Forecast By Product Type, 2014–2024
            14.2.1. Endovascular Stent Graft 
            14.2.2. Peripheral Vascular Graft 
            14.2.3. Hemodialysis Access Graft 
            14.2.4. Bypass Graft 
            14.2.5. Others
     14.3.Market Value Forecast By Source, 2014–2024
            14.3.1. Synthetic 
                     14.3.1.1. Polytetrafluethylene (PTFE)
                     14.3.1.2. Polyurethane (PU)
                     14.3.1.3. Dacron
                     14.3.1.4. Others
            14.3.2. Biological 
                     14.3.2.1. Bovine Vein
                     14.3.2.2. Saphenous Vein
                     14.3.2.3. Others
            14.3.3. Biosynthetic 
                     14.3.3.1. Ovine Collagen with Polyesters 
                     14.3.3.2. Others
     14.4.Market Value Forecast By Applications, 2014–2024
            14.4.1. Coronary Artery Disease
            14.4.2. Aneurysm
            14.4.3. Vascular Occlusion
            14.4.4. Renal Failure 
            14.4.5. Others
     14.5.Market Value Forecast By End Users, 2014–2024
            14.5.1. Hospitals
            14.5.2. Ambulatory Surgery Centers
            14.5.3. Cardiac Catheterization Laboratories 
            14.5.4. Specialty Clinics 
            14.5.5. Others
     14.6.Market Value Forecast By Country, 2014–2024
            14.6.1. GCC Countries
            14.6.2. South Africa 
            14.6.3. Rest of Middle East & Africa
     14.7.Market Attractiveness Analysis 
            14.7.1. By Product Type 
            14.7.2. By Source 
            14.7.3. By Applications
            14.7.4. By End Users 
            14.7.5. By Country

15. Competition Landscape
     15.1.Market Player – Competition Matrix (By Tier and Size of
     companies)
     15.2.Market Share Analysis, By Company - 2016 (Estimated)
     15.3.Company Profiles (Details – Overview, Financials, 
     Recent Developments, Strategy)
            15.3.1. LeMaitre Vascular, Inc.
                     15.3.1.1. Overview
                     15.3.1.2. Financials
                     15.3.1.3. Recent Developments
                     15.3.1.4. Strategy
            15.3.2. ARTEGRAFT
                     15.3.2.1. Overview
                     15.3.2.2. Financials
                     15.3.2.3. Recent Developments
                     15.3.2.4. Strategy
            15.3.3. Vascutek Ltd.
                     15.3.3.1. Overview
                     15.3.3.2. Financials
                     15.3.3.3. Recent Developments
                     15.3.3.4. Strategy 
            15.3.4. W. L. Gore & Associates, Inc.
                     15.3.4.1. Overview
                     15.3.4.2. Financials
                     15.3.4.3. Recent Developments
                     15.3.4.4. Strategy
            15.3.5. Vascular Grafts Solutions Ltd.
                     15.3.5.1. Overview
                     15.3.5.2. Financials
                     15.3.5.3. Recent Developments
                     15.3.5.4. Strategy
            15.3.6. Heart Medical Europe BV
                     15.3.6.1. Overview
                     15.3.6.2. Financials
                     15.3.6.3. Recent Developments
                     15.3.6.4. Strategy
            15.3.7. C.R. Bard, Inc.
                     15.3.7.1. Overview
                     15.3.7.2. Financials
                     15.3.7.3. Recent Developments
                     15.3.7.4. Strategy
            15.3.8. MAQUET Holding B.V. & Co. KG
                     15.3.8.1. Overview
                     15.3.8.2. Financials
                     15.3.8.3. Recent Developments
                     15.3.8.4. Strategy
            15.3.9. CryoLife Inc.
                     15.3.9.1. Overview
                     15.3.9.2. Financials
                     15.3.9.3. Recent Developments
                     15.3.9.4. Strategy
            15.3.10. Cook Medical, Inc.
                     15.3.10.1. Overview
                     15.3.10.2. Financials
                     15.3.10.3. Recent Developments
                     15.3.10.4. Strategy
            15.3.11. B. Braun Melsungen AG
                     15.3.11.1. Overview
                     15.3.11.2. Financials
                     15.3.11.3. Recent Developments
                     15.3.11.4. Strategy
            15.3.12. Medtronic plc
                     15.3.12.1. Overview
                     15.3.12.2. Financials
                     15.3.12.3. Recent Developments
                     15.3.12.4. Strategy 
            15.3.13. Others
                     15.3.13.1. Overview
                     15.3.13.2. Financials
                     15.3.13.3. Recent Developments
                     15.3.13.4. Strategy

16. Key Take Aways

List of Tables

Table 01: Global Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 02: Global Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 03: Global Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 04: Global Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 05: Global Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 06: Global Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 07: Global Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 08: Global Vascular Graft Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 09: North America Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 10: North America Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 11: North America Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 12: North America Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 13: North America Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 14: North America Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 15: North America Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 16: North America Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 18: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 19: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 20: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 21: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 22: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 23: Europe Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 24: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 25: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 26: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 27: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 28: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 29: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 30: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 31: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 32: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 33: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 34: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 35: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 36: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 37: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 38: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 39: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 40: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 41: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 42: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 43: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 44: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 45: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 46: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 47: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 48: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024

 

List of Figures

FIG 01: Global Vascular Graft Market Size (US$ Mn) Forecast, 2014–2024
FIG 02: Vascular Graft Market Value Share, by Product (2016)
FIG 03: Vascular Graft Market Value Share, by Application (2016)
FIG 04: Vascular Graft Market Value Share, by End-user (2016)
FIG 05: Vascular Graft Market Value Share, by Source (2016)
FIG 06: Vascular Graft Market Value Share, by Region (2016)
FIG 07: Global Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 08: Global Vascular Graft Market Attractiveness, by Product, 2016-2024
FIG 09: Global Vascular Graft Market, By Endovascular Stent Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 10: Global Vascular Graft Market, By Peripheral Vascular Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 11: Global Vascular Graft Market, By Hemodialysis Access Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 12: Global Vascular Graft Market, By Bypass Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 13: Global Vascular Graft Market, By Others Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 14: Global Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 15: Global Vascular Graft Market Attractiveness, by Source, 2016-2024
FIG 16: Global Vascular Graft Market, By Synthetic Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 17: Global Vascular Graft Market, By Biological Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 18: Global Vascular Graft Market, Biosynthetic Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 19: Global Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 20: Global Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 21: Global Vascular Graft Market, By Coronary Artery Disease Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 22: Global Vascular Graft Market, By Aneurysm Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 23: Global Vascular Graft Market, By Vascular Occlusion Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 24: Global Vascular Graft Market, By Renal Failure Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 25: Global Vascular Graft Market, By Others Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 26: Global Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 27: Global Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 28: Global Vascular Graft Market, by Hospital, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 29: Global Vascular Graft Market, by Ambulatory Surgical Centers, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 30: Global Vascular Graft Market, by Cardiac Catheterization Laboratories, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 31: Global Vascular Graft Market, by Specialty Clinics, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 32: Global Vascular Graft Market, By Others Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 33: Global Vascular Graft Market Value Share, by Region, 2016 and 2024
FIG 34: Global Vascular Graft Market Attractiveness, by Region, 2016-2024
FIG 35: North America Vascular Graft Market (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
FIG 36: North America Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 37: North America Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG38: North America Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 39: North America Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 40: North America Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 41: North America Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 42: North America Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 43: North America Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 44: North America Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 45: North America Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 46: Europe Vascular Graft Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
FIG 47: Europe Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 48: Europe Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 49: Europe Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 50: Europe Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 51: Europe Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 52: Europe Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 53: Europe Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 54: Europe Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 55: Europe Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 56: Europe Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 57: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2014–2024
FIG 58: Asia Pacific Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 59: Asia Pacific Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 60: Asia Pacific Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 61: Asia Pacific Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 62: Asia Pacific Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 63: Asia Pacific Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 64: Asia Pacific Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 65: Asia Pacific Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 66: Asia Pacific Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 67: Asia Pacific Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 68: Latin America Vascular Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG 69: Latin America Vascular Graft Market Attractiveness Analysis, by Country, 2016–2024
FIG 70: Latin America Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 71: Latin America Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 72: Latin America Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 73: Latin America Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 74: Latin America Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 75: Latin America Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 76: Latin America Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 77: Latin America Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 78: Latin America Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 79: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, 2014–2024
FIG 80: Middle East & Africa Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 81: Middle East & Africa Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 82: Middle East & Africa Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 83: Middle East & Africa Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 84: Middle East & Africa Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 85: Middle East & Africa Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 86: Middle East & Africa Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 87: Middle East & Africa Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 88: Middle East & Africa Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 89: Middle East & Africa Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 90: Global Vascular Graft Market Share Analysis, by Company (2016) 

.